ProteinQure Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
32
- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$104K
- Investors
-
30
ProteinQure General Information
Description
Operator of a biotech company intended to focus on the design of novel exotic peptides with broad therapeutic applications. The company specializes in leveraging quantum computing, molecular simulations, and reinforcement learning to facilitate novel therapeutics engineering, enabling researchers and drug developers to engineer and design protein structures with efficiency.
Contact Information
Website
www.proteinqure.comCorporate Office
- 108 College Street
- Suite 580
- Toronto, Ontario M5G 0C6
- Canada
Corporate Office
- 108 College Street
- Suite 580
- Toronto, Ontario M5G 0C6
- Canada
ProteinQure Timeline
ProteinQure Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 15. Accelerator/Incubator | 01-Jan-2025 | $104K | Completed | Clinical Trials - Phase 1 | ||
| 14. Later Stage VC (Series A) | 25-Sep-2024 | Completed | Clinical Trials - Phase 1 | |||
| 13. Later Stage VC | 01-Jan-2024 | Completed | Clinical Trials - Phase 1 | |||
| 12. Secondary Transaction - Private | 24-Jan-2022 | Completed | Clinical Trials - Phase 1 | |||
| 11. Accelerator/Incubator | 14-Oct-2020 | Completed | Clinical Trials - Phase 1 | |||
| 10. Accelerator/Incubator | 09-Oct-2020 | Completed | Clinical Trials - Phase 1 | |||
| 9. Accelerator/Incubator | Completed | Clinical Trials - Phase 1 | ||||
| 8. Seed Round | 29-Jul-2019 | Completed | Clinical Trials - Phase 1 | |||
| 7. Accelerator/Incubator | 12-Sep-2018 | $602K | Completed | Clinical Trials - Phase 1 | ||
| 6. Seed Round | 01-Jul-2018 | $472K | $602K | Completed | Clinical Trials - Phase 1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
ProteinQure Comparisons
Industry
Financing
Details
ProteinQure Competitors (63)
One of ProteinQure’s 63 competitors is Manifold Bio, a Venture Capital-Backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Manifold Bio | Venture Capital-Backed | Boston, MA | ||||
| Deep Genomics | Venture Capital-Backed | Toronto, Canada | ||||
| LabGenius Therapeutics | Venture Capital-Backed | London, United Kingdom | ||||
| Terray Therapeutics | Venture Capital-Backed | Monrovia, CA | ||||
| Protai Bio | Venture Capital-Backed | Ramat Gan, Israel |
ProteinQure Patents
ProteinQure Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260183411-A1 | Targeting sortilin | Pending | 10-May-2024 | ||
| WO-2025235912-A2 | Targeting sortilin | Pending | 10-May-2024 | ||
| WO-2025235912-A3 | Targeting sortilin | Pending | 10-May-2024 | ||
| WO-2025222300-A1 | Atrial natriuretic peptide constructs for targeted payload delivery to npr-c expressing cells | Pending | 24-Apr-2024 | ||
| AU-2023389980-A1 | Targeting sortilin | Pending | 06-Dec-2022 | A61K47/645 |
ProteinQure Signals
ProteinQure Investors (30)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Federal Economic Development Agency for Southern Ontario | Government | Minority | ||
| Ontario Genomics | Accelerator/Incubator | Minority | ||
| Canadian Medical Isotope Ecosystem | Venture Capital | Minority | ||
| Esalen Ventures | Venture Capital | Minority | ||
| Kensington Capital Partners | PE/Buyout | Minority |
ProteinQure FAQs
-
When was ProteinQure founded?
ProteinQure was founded in 2017.
-
Where is ProteinQure headquartered?
ProteinQure is headquartered in Toronto, Canada.
-
What is the size of ProteinQure?
ProteinQure has 32 total employees.
-
What industry is ProteinQure in?
ProteinQure’s primary industry is Drug Discovery.
-
Is ProteinQure a private or public company?
ProteinQure is a Private company.
-
What is ProteinQure’s current revenue?
The current revenue for ProteinQure is .
-
How much funding has ProteinQure raised over time?
ProteinQure has raised $15.7M.
-
Who are ProteinQure’s investors?
Federal Economic Development Agency for Southern Ontario, Ontario Genomics, Canadian Medical Isotope Ecosystem, Esalen Ventures, and Kensington Capital Partners are 5 of 30 investors who have invested in ProteinQure.
-
Who are ProteinQure’s competitors?
Manifold Bio, Deep Genomics, LabGenius Therapeutics, Terray Therapeutics, and Protai Bio are some of the 63 competitors of ProteinQure.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process